Qing Xi Ooi supports clients with hands-on analysis and strategic advice

Viviana Moroso brings scientific depth to quality control

Siv Jönsson develops Pharmetheus’s learning agenda
Events
News

Contact us

Home
About us
People
Lénaïg Tanneau

Lénaïg Tanneau

Lénaïg Tanneau, Ph.D.

Director, MIDD Consultant

Google scholar

Joined Pharmetheus in 2022, actively working in client projects
Expertise includes QTc modeling and pharmacometrics in therapeutic areas such as infectious diseases and oncology
Previously worked as pharmacometrician at Ipsen, France, as contract researcher at Uppsala University in collaboration with Merck KGaA, and as temporary MIDD Consultant at Pharmetheus, Sweden
M.Sc. in Pharmacokinetics (2014) from Paris Descartes University, France, Pharm.D. (2015) from University of Nantes, France, and Ph.D. in Pharmacometrics (2022) from Uppsala University, Sweden

Pharmetheus affiliated publications

Population pharmacokinetics and pharmacodynamics of depemokimab in people with asthma and chronic rhinosinusitis with nasal polyps Assessment of Phase 1 pharmacokinetic-pharmacodynamic predictions, based on Phase 3 clinical trials results. Depemokimab pharmacokinetics and response in blood eosinophil count reduction for asthma and chronic rhinosinusitis with nasal polyps patients Use of informative prior distributions from mepolizumab data to support depemokimab PKPD model analysis

Contact

Pharmetheus AB
Kungsängstull 4  
753 19 Uppsala, Sweden

Visiting address:  
Dragarbrunnsgatan 77, 5th floor

LinkedIn
YouTube

Services & Science
Quick links

About Pharmetheus

Pharmetheus is a consultancy firm helping clients reduce uncertainty in technical and regulatory processes, increasing confidence in the development of new medicines that can improve patients’ lives.

Whistleblower
Privacy Policy
Cookie Policy